Tajikistan Medical Device Imports: Thirteen Exempt Cases under Article 26(8)

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Tajik law enumerates thirteen situations in which import and export may take place without being subject to state registration. Article 26(8) of Law No. 1893 provides that a limited quantity of medicines and medical devices may be imported into and exported from the Republic of Tajikistan irrespective of their state registration, in the following situations. GRZAN makes two points. First, these thirteen exemptions must be used in combination with the nine registration-free situations of Article 17(4) – where registration itself is waived, the import still needs its own basis. Second, the key word of the exemption is a limited quantity; quantities exceeding what is reasonable do not enjoy the exemption.

2. Legal basis

ItemContent
Legal basisLaw of the Republic of Tajikistan on Medicines, Medical Devices and Pharmaceutical Activity No. 1893 of July 19, 2022 (re-enacted by Law No. 2181 of May 14, 2025)
Exemption clauseArticle 26(8): 13 items in total
Item 1Personal use of natural persons arriving in the Republic of Tajikistan
Item 2Staff of diplomatic missions accredited in the Republic of Tajikistan or representatives of international organisations
Item 3Treatment of passengers on means of transport located in the territory of the Republic of Tajikistan
Item 4Conduct of preclinical and clinical trials
Item 5Conducting expert review, registration, re-registration and making changes and additions to the submitted documents for medicines and medical devices in the Republic of Tajikistan
Item 6Display at exhibitions, trade fairs and conferences, without the right of sale
Item 7Treatment of participants in international political, cultural and sports events and international inspections
Item 8Use of standard samples of medicines and medical devices in preclinical and clinical research
Item 9Prevention and elimination of emergency situations
Item 10Use as an integral part of medical equipment and devices, on condition that they are not used directly or independently for medical or pharmaceutical purposes
Item 11Scientific research work
Item 12Introduction of innovative medical and pharmaceutical technologies
Item 13Export by natural persons of the necessary quantity for personal use
Companion clauseArticle 17(4)(7) and (9): exhibition samples and research samples are exempt from state registration
Prohibition clauseArticle 26(2): unregistered medicines and medical devices are prohibited from import and export, except in the situations provided by paragraphs 7 and 8

3. Expert insights

Insight 1: Item 5, together with Article 17(4)(9) and Article 26(3)(3), forms a complete registration sample channel. Article 26(8)(5) allows importation for the purpose of expert review, registration, re-registration and changes to the submitted documents; Article 17(4)(9) lists such samples among the situations exempt from state registration; Article 26(3)(3) lists foreign manufacturers and their authorised persons as entitled subjects. Taken together, the three provisions form the complete legal basis for sample importation during the registration stage. GRZAN recommends citing the three provisions as a group; none of them is sufficient alone.

Insight 2: Item 10 is the dedicated clause for equipment products, and its practical value is often underestimated. The provision allows the import and export of medicines and medical devices that serve as an integral part of medical equipment and devices and are not used directly or independently for medical or pharmaceutical purposes. The typical scenario is that calibrators, quality control materials, reagents and consumables supplied with an instrument may be imported together with the main unit without separate registration, provided they do not constitute an independently used product. This is an important channel for items accompanying large equipment, but two conditions must be met: the item must be inseparable from the equipment, and it must not be used independently.

Insight 3: Item 6 corresponds strictly to Article 17(4)(7). Item 6 is worded as display at exhibitions, trade fairs and conferences without the right of sale; Article 17(4)(7) refers to samples of medicines and medical devices used for exhibition without the right of further sale. Both emphasise the absence of any right of sale. GRZAN notes that giving samples away after the event, reselling them, or leaving them with a local institution would void the exemption and could trigger the withdrawal from circulation for unregistered products under Article 21(1)(1).

Insight 4: Items 1 and 13 cover inbound personal use and outbound personal use respectively – opposite directions. Item 1 covers personal use of natural persons arriving in the Republic of Tajikistan; item 13 covers export by natural persons of the necessary quantity for personal use. Together the two items confirm that articles for personal use are not subject to registration. GRZAN notes that the subject of both items is the natural person; a company cannot claim their application on the ground that the product is ultimately used by individuals.

Insight 5: Item 9, together with Article 26(7) and Article 17(9), forms the emergency situation channel. Item 9 allows importation for the prevention and elimination of emergency situations; Article 26(7) allows the Ministry of Health to permit a one-time importation of unregistered products in the event of natural disasters and emergencies, including infectious disease epidemics; Article 17(9) provides for simplified state registration. Together the three provisions cover both importation and registration during emergencies. GRZAN recommends preparing the three as a group in humanitarian and emergency projects.

4. Practical recommendations

  1. Cite all three bases together when importing registration samples. Under Article 26(8)(5), Article 17(4)(9) and Article 26(3)(3), cite all three provisions simultaneously in the sample importation documents to form a complete chain of basis.
  2. Assess the applicability of item 10 to items supplied with equipment. For calibrators, quality control materials, reagents and consumables imported with the main unit, assess whether the two conditions of inseparability and no independent use are met; if so, state this in the importation documents and invoke item 10.
  3. Keep a full audit trail for exhibition samples. Under item 6 and Article 17(4)(7), maintain inbound and outbound inventory records and final disposal records demonstrating that there is no right of sale, avoiding the withdrawal ground of Article 21(1)(1).
  4. Do not claim items 1 or 13 on the ground of ultimate personal use. The subject of these two items is the natural person; corporate importation does not qualify. Make this boundary explicit in internal training.
  5. Prepare the three bases as a package for emergency projects. Under Article 26(8)(9), Article 26(7) and Article 17(9), prepare the import documentation, the one-time importation permit and the simplified registration application in parallel in humanitarian and emergency projects.

5. Verification checklist

  • □ Compared the thirteen exemption situations of Article 26(8) item by item
  • □ Cited Article 26(8)(5), Article 17(4)(9) and Article 26(3)(3) together in the registration sample importation documents
  • □ Assessed whether items supplied with equipment meet the conditions of inseparability and no independent use under item 10
  • □ Built inbound and outbound inventory records and final disposal records for exhibition samples (item 6, Article 17(4)(7))
  • □ Confirmed that items 1 and 13 are not claimed on the ground of ultimate personal use
  • □ Prepared the three bases of Article 26(8)(9), Article 26(7) and Article 17(9) in parallel for emergency projects
  • □ Confirmed that exempted quantities are limited quantities and retained a justification of quantity reasonableness

Regulatory information verified as of October 29, 2026.

In the Central Asian market, the core capabilities of GRZAN focus on three points. First, distinguishing the different legal positions of each market within the Eurasian Economic Union: Kazakhstan and Kyrgyzstan are full member states where a choice exists between a national pathway and a Union pathway; Uzbekistan is an observer state with only a national pathway; Tajikistan and Turkmenistan are outside the Union framework and must follow purely national procedures. Second, local authorised representative services: GRZAN can act as the statutory representative of manufacturers in the above countries, undertaking registration submission, regulatory communication and post-market reporting obligations. Third, quality system and testing support: GRZAN assists in establishing a quality management system conforming to ISO 13485 and connects clients with locally accredited laboratory resources.

For business inquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail